Revance Therapeutics Inc (RVNC) Rapporto sugli Utili - Previsioni e Surprise Ratio

Pubblicita'

Storico dei ricavi trimestrali

RVNC rapporto: 43%

100%

RVNC supera 15 di 35 ultime stime

Data del prossimo reportNov 13, 2024

Stimato per Q4 24:$-0.36

Cambiamenti implicati per il Q3 24:0.00%

Cambiamenti implicati per il Q4 23:-51.35%

Periodo Bilanci	Data Riportata	EPS / Previsioni	Sorpresa
Q3 24	Nov 7, 2024	$-0.37 / $-0.35	$-0.02 / -5.71%
Q2 24	Aug 8, 2024	$-0.36 / $-0.48	$0.12 / 25%
Q1 24	May 9, 2024	$-0.54 / $-0.66	$0.12 / 18.18%
Q4 23	Feb 28, 2024	$-0.62 / $-0.79	$0.17 / 21.52%
Q3 23	Nov 8, 2023	$-0.74 / $-1.02	$0.28 / 27.45%
Q2 23	Aug 8, 2023	$-0.8 / $-0.72	$-0.08 / -11.11%
Q1 23	May 9, 2023	$-0.74 / $-0.75	$0.01 / 1.33%
Q4 22	Feb 28, 2023	$-1.82 / $-1.04	$-0.78 / -75%

Fornitori di Dati: Xignite Logo